Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series

Abstract Most of the post‐renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti‐proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post‐renal transplant patients with severe COVID‐19...

Full description

Bibliographic Details
Main Authors: Nissar Shaikh, Mohamad Y. Khatib, Mohammad A. Alwraidat, Dore C. Ananthegowda, Muftah Othman, Asra Aroos, Sagar B. Jujjavarapu, Saptarshi Banerjee, Zishan Nasir, Ahmed S. Mohamed, Moustafa S. Elshafei, Muna A. Almaslamani, Abdulqadir J. Nashwan
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.4513
id doaj-127554525125483faa9d05a1818c51fb
record_format Article
spelling doaj-127554525125483faa9d05a1818c51fb2021-07-29T07:58:46ZengWileyClinical Case Reports2050-09042021-07-0197n/an/a10.1002/ccr3.4513Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case seriesNissar Shaikh0Mohamad Y. Khatib1Mohammad A. Alwraidat2Dore C. Ananthegowda3Muftah Othman4Asra Aroos5Sagar B. Jujjavarapu6Saptarshi Banerjee7Zishan Nasir8Ahmed S. Mohamed9Moustafa S. Elshafei10Muna A. Almaslamani11Abdulqadir J. Nashwan12Surgical Intensive Care Department Hamad General Hospital (HGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarNephrology Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarNephrology Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarNephrology Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarCommunicable Diseases Center (CDC) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarAbstract Most of the post‐renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti‐proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post‐renal transplant patients with severe COVID‐19 infection admitted to the intensive care unit.https://doi.org/10.1002/ccr3.4513acute kidney injuryCOVID‐19 infectionend‐stage renal diseasehypertensionimmunosuppressionrenal transplant
collection DOAJ
language English
format Article
sources DOAJ
author Nissar Shaikh
Mohamad Y. Khatib
Mohammad A. Alwraidat
Dore C. Ananthegowda
Muftah Othman
Asra Aroos
Sagar B. Jujjavarapu
Saptarshi Banerjee
Zishan Nasir
Ahmed S. Mohamed
Moustafa S. Elshafei
Muna A. Almaslamani
Abdulqadir J. Nashwan
spellingShingle Nissar Shaikh
Mohamad Y. Khatib
Mohammad A. Alwraidat
Dore C. Ananthegowda
Muftah Othman
Asra Aroos
Sagar B. Jujjavarapu
Saptarshi Banerjee
Zishan Nasir
Ahmed S. Mohamed
Moustafa S. Elshafei
Muna A. Almaslamani
Abdulqadir J. Nashwan
Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series
Clinical Case Reports
acute kidney injury
COVID‐19 infection
end‐stage renal disease
hypertension
immunosuppression
renal transplant
author_facet Nissar Shaikh
Mohamad Y. Khatib
Mohammad A. Alwraidat
Dore C. Ananthegowda
Muftah Othman
Asra Aroos
Sagar B. Jujjavarapu
Saptarshi Banerjee
Zishan Nasir
Ahmed S. Mohamed
Moustafa S. Elshafei
Muna A. Almaslamani
Abdulqadir J. Nashwan
author_sort Nissar Shaikh
title Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series
title_short Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series
title_full Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series
title_fullStr Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series
title_full_unstemmed Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series
title_sort clinical outcomes of post‐renal transplant patients with covid‐19 infection in the icu: a single‐center case series
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2021-07-01
description Abstract Most of the post‐renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti‐proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post‐renal transplant patients with severe COVID‐19 infection admitted to the intensive care unit.
topic acute kidney injury
COVID‐19 infection
end‐stage renal disease
hypertension
immunosuppression
renal transplant
url https://doi.org/10.1002/ccr3.4513
work_keys_str_mv AT nissarshaikh clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
AT mohamadykhatib clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
AT mohammadaalwraidat clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
AT dorecananthegowda clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
AT muftahothman clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
AT asraaroos clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
AT sagarbjujjavarapu clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
AT saptarshibanerjee clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
AT zishannasir clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
AT ahmedsmohamed clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
AT moustafaselshafei clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
AT munaaalmaslamani clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
AT abdulqadirjnashwan clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries
_version_ 1721259119749365760